The global Biofeedback Measurement Instrument Market Growth Accelerated by Rising Demand for Stress Management and Wellbeing


Biofeedback measurement instruments help monitor and record physiological indicators of the body like brain waves, heart rate, breathing, muscle activity and skin temperature. They help understand the responses of the autonomic nervous system and aid in conditions like stress, anxiety, depression and chronic pain.

The global Biofeedback Measurement Instrument Market is estimated to be valued at US$ 185.4 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

With rising awareness about the benefits of stress management and well-being, the demand for biofeedback therapy has increased substantially over the years. Biofeedback treatment helps monitor stress levels in the body and control the autonomic nervous system through visual or auditory feedback. This has resulted in growing sales of biofeedback measurement instruments globally. Technological advancements have made these devices more portable and easy-to-use, further propelling the biofeedback measurement instrument market growth.

Segment Analysis

The global biofeedback measurement instrument market size is dominated by the healthcare segment. The healthcare segment accounts for over 65% share of the total market owing to rising adoption of biofeedback therapy in pain management, headache treatment, hypertension treatment and other conditions. Within the healthcare segment, rehabilitation centers hold the major share followed by hospitals. The growing need for non-drug and non-invasive pain management therapies is driving the demand for biofeedback instruments across various rehabilitation centers.

Key Takeaways

The global biofeedback measurement instrument market is expected to witness high growth over the forecast period of 2023-2030. Favorable reimbursement policies and growing acceptance of alternative therapies for chronic conditions across major countries is supporting the market expansion. The global Biofeedback Measurement Instrument Market is estimated to be valued at US$ 185.4 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030.

North America currently dominates the global market and is expected to maintain its top position during the forecast period. Growing healthcare expenditure, advanced healthcare infrastructure and increasing prevalence of lifestyle diseases are some major factors fueling the demand for biofeedback instruments in the region. Asia Pacific is anticipated to register fastest growth rate owing to rising medical tourism, improving access to healthcare services and expansion of healthcare ecosystem in emerging countries such as India, China and South Korea.

Key players operating in the biofeedback measurement instrument market are Thought Technology Ltd, ELMIKO, Mind Media, Laborie, Behavioral Medicine Associates, Inc, Neurocare Group Gmbh, Allengers Medical Systems, BrainMaster Technologies, Inc, Quantum World Vision, NCC Medical, Qxsubspace. Thought Technology Ltd and ELMIKO are recognized as industry leaders with wide range of products and global sales footprint.

Comments

Popular posts from this blog

Interior Fit Out Market Poised for Growth Accelerated by Modular Construction Growth

Solar Photovoltaic Glass Market Growth Accelerated by Sustainable Energy Drive

The Global Cyanate Ester Resins Market Growth Accelerated By Superior Properties Over Traditional Resins